The orthometalated complex [{Pd(μ-Cl){κ 2 - P, C -P(OC 6 H 2 -2,4- t Bu 2 )(OC 6 H 3 -2,4- t Bu 2 ) 2 }} 2 ] reacts with phenylboronic acid hydrate and K 2 CO 3 in dimethylacetamide to give [Pd{κ 2 - P, C -μ 2 - O -P(O)(C 6 H 2 -2,4- t Bu 2 )(C 6 H 3 -2,4- t Bu 2 )(DMAc)}]. When the reaction is repeated in dimethylformamide 3,3‘,5,5‘-tetra- tert -butyl-2,2‘-biphenol is isolated. Both compounds have been characterized crystallographically. The reaction of palladium dichloride with P i Pr 2 (OC 6 H 4 -4-Et) in 2-methoxyethanol followed by recrystallization in the presence of ethanol leads to the formation of trans -[PdCl 2 {P i Pr 2 (OEt)} 2 ], which was also characterized by crystallography. To determine whether related solvolytic processes have a bearing on catalytic activity, the performance of a range of catalysts with “hydrolyzed” and “nonhydrolyzed” ligands was assessed in the Suzuki coupling of aryl bromides. In some cases it was evident that hydrolysis plays a significant role on the catalytic activity; however, this depends not only on the ligand, but also on the combination of ligand and palladium precursor.
No takes yet. Share an insight, caveat, or question.
Bedford et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: